MBIO

Mustang Bio (MBIO)

About Mustang Bio (MBIO)

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Worcester, MA.

Details

Daily high
$0.24
Daily low
$0.21
Price at open
$0.23
52 Week High
$2.11
52 Week Low
$0.13
Market cap
7.9M
Dividend yield
0.00%
Volume
505,794
Avg. volume
500,668
P/E ratio
-.07

Mustang Bio News

Details

Daily high
$0.24
Daily low
$0.21
Price at open
$0.23
52 Week High
$2.11
52 Week Low
$0.13
Market cap
7.9M
Dividend yield
0.00%
Volume
505,794
Avg. volume
500,668
P/E ratio
-.07